Observational Study
Copyright ©The Author(s) 2020.
World J Diabetes. Nov 15, 2020; 11(11): 540-552
Published online Nov 15, 2020. doi: 10.4239/wjd.v11.i11.540
Table 3 Difference in antihyperglycemic therapy between three therapy groups
Therapy group

SGLT-2i, n (%)
GLP-1RA, n (%)
Simultaneous, n (%)
Insulin11 (32.4)28 (45.2)11 (26.2)
Metformin32 (94.1)53 (85.5)33 (78.6)
SU4 (11.8)12 (19.4)6 (14.3)
Other OAD3 (8.8)10 (16.1)8 (19.0)